You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 7, July 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters to the Editor
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (76)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Catechol-O-Methyltransferase Val-108/158-Met Gene Variants Associated With Performance on the Wisconsin Card Sorting Test

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Because of its location in a region previously linked to schizophrenia (22q),1 and its critical involvement in the homeostasis of dopamine metabolism in brain regions relevant for schizophrenia, such as the dorsolateral prefrontal cortex (DLPFC),2-3 it was hypothesized that allelic variants of the catechol-O-methyltransferase (COMT) gene may modulate the risk for this disorder. Recently, in accordance with this hypothesis, an allele coding for an isoform with high enzymatic activity of the COMT (Val allele of the Val-108/158-Met polymorphism) was associated or linked to schizophrenia.4 Moreover, it was shown in that study, part of the variance for the Wisconsin Card Sorting Test (WCST; a neuropsychological test that maps mainly into the DLPFC), performance was explained by the Val-108/158-Met polymorphism, both in schizophrenic patients and in healthy controls, where subjects carrying 1 or 2 copies of the Val allele performed significantly worse on . . . [Full Text of this Article]



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Catechol-o-Methyltransferase Enzyme Activity and Protein Expression in Human Prefrontal Cortex across the Postnatal Lifespan
Tunbridge et al.
Cereb Cortex 2007;17:1206-1212.
ABSTRACT | FULL TEXT  

Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome
Raux et al.
Hum Mol Genet 2007;16:83-91.
ABSTRACT | FULL TEXT  

Association of COMT Val158Met Genotype With Executive Functioning Following Traumatic Brain Injury
Lipsky et al.
J. Neuropsychiatry Clin. Neurosi. 2005;17:465-471.
ABSTRACT | FULL TEXT  

Catechol O-Methyltransferase Val158Met Polymorphism is Associated with Cognitive Performance in Nondemented Adults
de Frias et al.
J. Cogn. Neurosci. 2005;17:1018-1025.
ABSTRACT | FULL TEXT  

New Evidence of Association Between COMT Gene and Prefrontal Neurocognitive Function in Healthy Individuals From Sibling Pairs Discordant for Psychosis
Rosa et al.
Am. J. Psychiatry 2004;161:1110-1112.
ABSTRACT | FULL TEXT  

Executive Subprocesses in Working Memory: Relationship to Catechol-O-methyltransferase Val158Met Genotype and Schizophrenia
Goldberg et al.
Arch Gen Psychiatry 2003;60:889-896.
ABSTRACT | FULL TEXT  

Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine
Mattay et al.
Proc. Natl. Acad. Sci. USA 2003;100:6186-6191.
ABSTRACT | FULL TEXT  

Association Between a Functional Catechol O-Methyltransferase Gene Polymorphism and Schizophrenia: Meta-Analysis of Case-Control and Family-Based Studies
Glatt et al.
Am. J. Psychiatry 2003;160:469-476.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.